CD8A and neoplasm: Next to the baseline number of CD8+ CTL, recent studies demonstrated that the spatial distribution of tumor infiltrating lymphocytes (TIL), characterized by the concept of tumor immune phenotype, might also have a prognostic impact and determine the response to ICI.